Every Summer, #TeamGenerate takes a well-deserved week off over the Fourth of July to rest and recharge for what’s next. This break allows us to return with renewed energy and a fresh perspective, ready to continue pushing the boundaries of what’s possible. Accordingly, we will be closed next week and will be back on Monday, July 8. As one #FiercelyUnited organization, we’re looking forward to continuing to advance our vision of instantly generating optimal therapeutics for the greatest impact on human health. #AudaciouslyAmbitious I #UnapologeticallyScientific
Generate:Biomedicines
Biotechnology Research
Somerville, Massachusetts 25,960 followers
Pioneering generative biology to create breakthrough therapeutics.
About us
Pioneering generative biology to create breakthrough therapeutics.
- Website
-
https://generatebiomedicines.com/
External link for Generate:Biomedicines
- Industry
- Biotechnology Research
- Company size
- 201-500 employees
- Headquarters
- Somerville, Massachusetts
- Type
- Privately Held
Locations
-
Primary
101 South Street
Suite 900
Somerville, Massachusetts 02143, US
-
4 Corporate Dr.
Andover, Massachusetts 01810, US
Employees at Generate:Biomedicines
Updates
-
In his talk at the AI-Science Workshop at the Simons Institute for the Theory of Computing of the University of California, Berkeley, our Head of Machine Learning John Ingraham explained how generative models such as Chroma are allowing us to expand the protein repertoire on Earth and enable the programmable generation of fit-for-purpose medicines. This work relies on highly interdisciplinary collaborations between computation, biology, and engineering, and we are just getting started. Watch the full talk below for more of the lessons we have learned along the way: https://lnkd.in/edWAr4Ts Are you an #ML scientist looking to create new paradigms for drug discovery? If that is you, apply here: https://lnkd.in/e-xd-Cvz #GenerativeBiology | #UnapologeticallyScientific
Illuminating protein space with generative models
https://www.youtube.com/
-
How does a late-night email turn into a biotech revolution? Lillian Eden for Massachusetts Institute of Technology shares how our CTO Gevorg Grigoryan, after hours of perfecting an email, reached out to Noubar Afeyan, Founder & CEO of Flagship Pioneering, in the wee hours of the morning with an idea to use data-driven protein design for therapeutic applications. Just 15 minutes later, he got a response that led to co-founding Generate:Biomedicines, revolutionizing protein design using #AI and blending biology, physics, and computational sciences. Fast forward nearly six years, and Gevorg says: “Now, we can just push a button and have a generative model spit out a new protein with close to perfect probability it will actually work.” Discover how together, #TeamGenerate is harnessing the power of data and #MachineLearning to program biology and dramatically improve the human condition. Read the full article to explore the breakthrough: https://lnkd.in/dRvnTRQx #NowWeCan | #ProteinEngineering |#GenerativeBiology
-
In 2024, women make up just 15.7% of the engineering workforce, highlighting the ongoing efforts required to achieve gender parity. Today, we celebrate International Women in Engineering Day, which aims to raise awareness about the underrepresentation of women in engineering and celebrate their achievements. This day is crucial for promoting gender equality and encouraging more women and girls to pursue careers in engineering. Engineering is integral for #TeamGenerate, from automation technology to data analysis and software engineering. We’re proud to spotlight some of the talented women engineers on our team, including Tharindi Hapuarachchi, PhD, Julia K., and Yiqing (Melody) Wang, who drive our mission forward every day. Join us in celebrating their achievements and the vital role women play in engineering. #WomenInSTEM | #WomenInEngineering | #INWED2024
-
-
According to Mikaela Cohen from Morning Brew, #GenerativeAI has the potential to transform drug discovery by reducing time and costs. In Q1 2024, AI mentions in pharma filings rose by 45%. Alexandra Snyder, MD, our EVP of R&D, shared, "We've made significant strides notably advancing a COVID-19 therapy to clinical trials in just 17 months, a timeline far quicker than traditional methods. This demonstrates our AI-driven approach's efficiency in moving from concept to clinical testing at an unprecedented pace." Such advancements could enable rapid responses to future pandemics. Learn more about how AI is shaping the future of healthcare: https://lnkd.in/emScA6HE #GenerativeBiology | #ProgramableMedicine
How generative AI is shaping drug discovery
healthcare-brew.com
-
Geoffrey von Maltzahn, one of our Co-Founders and General Partner of Flagship Pioneering, shares his vision for the future of medicine in a recent interview with SARAH LISS at Toronto Star. Geoff states, “We believe that all future protein therapeutics will be created with the help of #GenerativeAI.” He adds that we are moving drug discovery from a lengthy, risky, trial-and-error process to one that is predictable and fast - generating new medicines in a fraction of the time and cost, with a much higher likelihood of success. Geoff further explains, “I believe medicine will look a lot different than it does today. As #AI continues to evolve, we’ll be able to generate treatments that offer unprecedented precision and effectiveness.” Discover more about how Geoff sees AI revolutionizing medicine. https://lnkd.in/e4JCRzuv #FlagshipFounded | #GenerativeBiology
Cracking the code: How generative biology can use patterns in our genetic material to cure diseases — and prevent them from developing in the first place
thestar.com
-
Today, we honor Father’s Day and mark the conclusion of Men’s Health Week, a time dedicated to highlighting the unique health challenges experienced by men. #TeamGenerate recognizes the crucial role fathers play in our lives and communities, including the dedicated fathers we work with every day. While our mission is to improve human health broadly, today we spotlight the importance of men’s health and the unique challenges they face. By advancing novel medicines where unmet needs exist, we strive to improve lives and ensure a healthier future for all. Learn more about Men’s Health Week here: https://lnkd.in/gGhZdu2w #NMHW I #MensHealthWeek
-
Continuing our momentum, we are also pleased to announce the addition of Nancy Simonian, M.D., to our Board of Directors. Dr. Simonian is a renowned leader in clinical development, known for her success in bringing new therapies to patients. As the founding CEO of Syros Pharmaceuticals, she transformed the company from a startup into a publicly traded late clinical-stage company. Her experience with developing groundbreaking therapies at Biogen (AVONEX and TYSABRI) and Millennium Pharmaceuticals (VELCADE and ENTYVIO) will significantly bolster our efforts to deliver next-generation therapeutics. Read the full release to learn more: https://lnkd.in/ePrpeJKb #PatientFocusedDrugDevelopment | #WomenInSTEM
-
-
We are excited to welcome Rupert Vessey, M.D., Ph.D., to our Board of Directors. Dr. Vessey brings a wealth of experience overseeing programs from initial drug discovery to proof-of-concept, as well as innovative bioplatforms. With a distinguished career at Bristol-Myers Squibb, Celgene, Merck, and GlaxoSmithKline, his strategic insights and hands-on experience will be invaluable as we advance The Generate Platform and our early-stage programs. Read the full release to learn more: https://lnkd.in/ePrpeJKb #GenerativeAI I #ProteinEngineering
-
-
“Our people, our employees, our scientists at Generate are the entire key to our success.” #ICYMI – Hear our CEO Michael Nally discuss the power of #TeamGenerate in CorrDyn’s latest Data in Biotech interview with Ross Katz. During the conversation, Mike highlights how our team’s unique blend of computational and experimental expertise sets us apart. Starting with our brilliant scientists - and amplifying their abilities with #GenerativeAI - we are pushing the boundaries of what’s possible. Want to join the #GenerativeBiology revolution? Check out our careers page for open positions: https://lnkd.in/gv9Ve3fd #UnapologeticallyScientific I #AudaciouslyAmbitious